Segall Bryant & Hamill, LLC Innoviva, Inc. Transaction History
Segall Bryant & Hamill, LLC
- $6.35 Billion
- Q1 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 36,867 shares of INVA stock, worth $686,832. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,867
Previous 36,867
-0.0%
Holding current value
$686,832
Previous $639,000
4.54%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding INVA
# of Institutions
256Shares Held
75MCall Options Held
2.3KPut Options Held
2.4K-
Black Rock Inc. New York, NY9.63MShares$179 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.3MShares$117 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$117 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.66MShares$86.8 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.56MShares$84.9 Million0.13% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.3B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...